Innocan Pharma Corp. buy Indyro
Start price
15.09.21
/
80%
€0.70
Target price
15.09.22
€2.00
Performance (%)
-41.34%
End price
17.05.22
€0.41
Summary
This prediction ended on 17.05.22 with a price of €0.41. The BUY prediction by Indyro for Innocan Pharma Corp. performed very badly with a performance of -41.34%. Indyro has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innocan Pharma Corp. | - | - | - | - |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% | 64.061% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% | 86.918% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% | 77.872% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% | 68.192% |
Comments by Indyro for this prediction
In the thread Innocan Pharma Corp. diskutieren
Buy Innocan Pharma Corp.